Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Dana-Farber Cancer Institute · Brigham and Women's Hospital · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
744
total citations
- FWCI
- 60.70
- Percentile
- 100%
- References
- 25
Citations per year
Authors
13- RIRobert I. HaddadCorresponding
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Harvard University
- AOAnne O’Neill
Dana-Farber Cancer Institute
- GRGuilherme Rabinowits
Dana-Farber Cancer Institute
- RBRoy B. Tishler
Dana-Farber Cancer Institute
- FRFadlo R. Khuri
Emory University
Topics & keywords
Topics
Keywords
- Chemoradiotherapy
- Head and neck cancer
- Medicine
- Induction chemotherapy
- Oncology
- Head and neck
- Chemotherapy
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.